Echocardiographic variables in the study population
| Echocardiography data . | Patients (n = 130) . |
|---|---|
| LV function and remodeling | |
| LVEF in Simpson biplane (%) | 58 ± 6 |
| LVEF <50%, n (%) | 8 (6) |
| GLS (%) | −17.9 ± 2.7 |
| Cardiac output (L/min) | 6.6 ± 1.8 |
| Indexed LV volume (mL/m2) | 82 ± 22 |
| Indexed LV mass (g/m2) | 108 ± 36 |
| Diastolic function | |
| E (cm/s) | 87 ± 24 |
| EDT (ms) | 190 ± 48 |
| A (cm/s) | 64 ± 22 |
| E/A | 1.5 ± 0.6 |
| E' lateral (cm/s) | 13 ± 4 |
| E/E'lateral | 8 ± 3 |
| Indexed LA volume (mL/m2) | 57 ± 19 |
| Right ventricular function and right pressures | |
| TAPSE (mm) | 25 ± 5 |
| S-wave (cm/s) | 14 ± 3 |
| TRV (m/s), n = 124 | 2.6 ± 0.3 |
| TRV ≥3 m/s, n (%) | 23 (19) |
| Pulmonary acceleration time (ms) | 132 ± 31 |
| Indexed tricuspid ring (mm/m2) | 19 ± 3 |
| Telesystolic area of the right atrium (cm2) | 20 ± 6 |
| Systolic pulmonary arterial pressure (mm Hg) | 33 ± 9 |
| Right atrium pressure (mm Hg) | 5 ± 3 |
| Valve disease | |
| Severe valve disease (grade 4), n (%) | 1 (1) |
| Mild to moderate valve disease (grades 2 and 3), n (%) | 15 (12) |
| Echocardiography data . | Patients (n = 130) . |
|---|---|
| LV function and remodeling | |
| LVEF in Simpson biplane (%) | 58 ± 6 |
| LVEF <50%, n (%) | 8 (6) |
| GLS (%) | −17.9 ± 2.7 |
| Cardiac output (L/min) | 6.6 ± 1.8 |
| Indexed LV volume (mL/m2) | 82 ± 22 |
| Indexed LV mass (g/m2) | 108 ± 36 |
| Diastolic function | |
| E (cm/s) | 87 ± 24 |
| EDT (ms) | 190 ± 48 |
| A (cm/s) | 64 ± 22 |
| E/A | 1.5 ± 0.6 |
| E' lateral (cm/s) | 13 ± 4 |
| E/E'lateral | 8 ± 3 |
| Indexed LA volume (mL/m2) | 57 ± 19 |
| Right ventricular function and right pressures | |
| TAPSE (mm) | 25 ± 5 |
| S-wave (cm/s) | 14 ± 3 |
| TRV (m/s), n = 124 | 2.6 ± 0.3 |
| TRV ≥3 m/s, n (%) | 23 (19) |
| Pulmonary acceleration time (ms) | 132 ± 31 |
| Indexed tricuspid ring (mm/m2) | 19 ± 3 |
| Telesystolic area of the right atrium (cm2) | 20 ± 6 |
| Systolic pulmonary arterial pressure (mm Hg) | 33 ± 9 |
| Right atrium pressure (mm Hg) | 5 ± 3 |
| Valve disease | |
| Severe valve disease (grade 4), n (%) | 1 (1) |
| Mild to moderate valve disease (grades 2 and 3), n (%) | 15 (12) |
The ordinal data are reported as mean ± standard deviation and the nominal data are reported as absolute value and percentage.
A, mitral end-diastolic velocity; ASE, American Society of Echocardiography; E, mitral protodiastolic velocity; E', mitral protodiastolic annular velocity; EDT, E wave deceleration time; GLS, global longitudinal strain; LVEDVi, indexed LV end-diastolic volume; S, tricuspid annular mesosystolic velocity; TAPSE, tricuspid annular plane systolic excursion.